These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
413 related articles for article (PubMed ID: 31871924)
1. Long Noncoding RNA GATA3-AS1 Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Suppression of PTEN, CDKN1A, and TP53. Luo X; Zhou N; Wang L; Zeng Q; Tang H Can J Gastroenterol Hepatol; 2019; 2019():1389653. PubMed ID: 31871924 [TBL] [Abstract][Full Text] [Related]
2. Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway. Song W; Zhang J; Xia Q; Sun M Cell Cycle; 2019 Nov; 18(22):3177-3188. PubMed ID: 31564201 [No Abstract] [Full Text] [Related]
3. lncRNA A1BG-AS1 suppresses proliferation and invasion of hepatocellular carcinoma cells by targeting miR-216a-5p. Bai J; Yao B; Wang L; Sun L; Chen T; Liu R; Yin G; Xu Q; Yang W J Cell Biochem; 2019 Jun; 120(6):10310-10322. PubMed ID: 30556161 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of LncRNA FAM83H-AS1 in hepatocellular carcinoma promotes cell proliferation, migration and invasion by Wnt/β-catenin pathway. Ma YK; Shen TH; Yang XY Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7855-7862. PubMed ID: 31599410 [TBL] [Abstract][Full Text] [Related]
5. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188 [TBL] [Abstract][Full Text] [Related]
6. MiR-718 mediates the indirect interaction between lncRNA SEMA3B-AS1 and PTEN to regulate the proliferation of hepatocellular carcinoma cells. Zhong Y; Li Y; Song T; Zhang D Physiol Genomics; 2019 Oct; 51(10):500-505. PubMed ID: 31251699 [TBL] [Abstract][Full Text] [Related]
7. RNF185-AS1 promotes hepatocellular carcinoma progression through targeting miR-221-5p/integrin β5 axis. Huang C; Li K; Huang R; Zhu J; Yang J Life Sci; 2021 Feb; 267():118928. PubMed ID: 33358902 [TBL] [Abstract][Full Text] [Related]
8. LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis. Zhang L; Wang L; Wang Y; Chen T; Liu R; Yang W; Liu Q; Tu K Biomed Pharmacother; 2019 Jan; 109():1140-1147. PubMed ID: 30551364 [TBL] [Abstract][Full Text] [Related]
9. A novel long noncoding RNA HHIP-AS1 suppresses hepatocellular carcinoma progression through stabilizing HHIP mRNA. Bo C; Li X; He L; Zhang S; Li N; An Y Biochem Biophys Res Commun; 2019 Dec; 520(2):333-340. PubMed ID: 31604528 [TBL] [Abstract][Full Text] [Related]
10. lncRNA RBM5-AS1 promotes cell proliferation and invasion by epigenetically silencing miR-132/212 in hepatocellular carcinoma cells. Mu JY; Tian JX; Chen YJ Cell Biol Int; 2021 Nov; 45(11):2201-2210. PubMed ID: 34019714 [TBL] [Abstract][Full Text] [Related]
11. The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation. Li S; Huang Y; Huang Y; Fu Y; Tang D; Kang R; Zhou R; Fan XG J Exp Clin Cancer Res; 2017 Apr; 36(1):51. PubMed ID: 28403886 [TBL] [Abstract][Full Text] [Related]
12. RHPN1-AS1 Drives the Progression of Hepatocellular Carcinoma via Regulating miR-596/IGF2BP2 Axis. Fen H; Hongmin Z; Wei W; Chao Y; Yang Y; Bei L; Zhihua S Curr Pharm Des; 2020; 25(43):4630-4640. PubMed ID: 31692433 [TBL] [Abstract][Full Text] [Related]
13. LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis. Zhang YT; Li BP; Zhang B; Ma P; Wu QL; Ming L; Xie LM Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6333-6341. PubMed ID: 30338801 [TBL] [Abstract][Full Text] [Related]
14. The lncRNA Zhou N; Li S; Wu D; Zhang F; Tang F; Li Y DNA Cell Biol; 2021 Oct; 40(10):1278-1289. PubMed ID: 34558987 [TBL] [Abstract][Full Text] [Related]
15. LncRNA ID2-AS1 suppresses tumor metastasis by activating the HDAC8/ID2 pathway in hepatocellular carcinoma. Zhou Y; Huan L; Wu Y; Bao C; Chen B; Wang L; Huang S; Liang L; He X Cancer Lett; 2020 Jan; 469():399-409. PubMed ID: 31730902 [TBL] [Abstract][Full Text] [Related]
17. LncRNA THAP9-AS1 highly expressed in tissues of hepatocellular carcinoma and accelerates tumor cell proliferation. Su Y; Xie R; Xu Q Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102025. PubMed ID: 36170961 [TBL] [Abstract][Full Text] [Related]
18. LncRNA SOX21-AS1 is associated with progression of hepatocellular carcinoma and predicts prognosis through epigenetically silencing p21. Wei C; Wang H; Xu F; Liu Z; Jiang R Biomed Pharmacother; 2018 Aug; 104():137-144. PubMed ID: 29772433 [TBL] [Abstract][Full Text] [Related]
19. Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma. Wang Y; Jing W; Ma W; Liang C; Chai H; Tu J Cancer Biomark; 2018; 22(2):227-236. PubMed ID: 29660898 [TBL] [Abstract][Full Text] [Related]
20. The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1. Ding CH; Yin C; Chen SJ; Wen LZ; Ding K; Lei SJ; Liu JP; Wang J; Chen KX; Jiang HL; Zhang X; Luo C; Xie WF Mol Cancer; 2018 Feb; 17(1):63. PubMed ID: 29466992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]